Skip to main content
Year archive

Camurus — 2021 filings

All 43 regulatory filings released by Camurus (CAMX) in 2021, sourced directly from the official regulator.

43 Filings
2021 Period
2021 filings (43)
Filing Released Lang
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-30 English
Change in number of shares and votes in Camurus
Share Issue/Capital Change
2021-12-30 English
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change
2021-12-30 Swedish
Major Shareholding Notification 2021
Major Shareholding Notification
2021-12-20 English
Braeburn erhåller nytt CRL för Brixadi i USA
Legal Proceedings Report
2021-12-15 Swedish
Braeburn receives new Complete Response Letter for Brixadi in the US
Regulatory Filings
2021-12-15 English
Declaration of Voting Results & Voting Rights Announcements 2021
Declaration of Voting Results & Voting Rights Announcements
2021-12-07 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-11-05 English
Interim / Quarterly Report 2021
Interim / Quarterly Report 9M 2021
2021-11-04 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q3 2021
2021-11-04 English
Valberedning utsedd inför Camurus årsstämma 2022
Board/Management Information
2021-10-27 Swedish
Camurus’ Nomination Committee appointed for the Annual General Meeting 2022
Board/Management Information
2021-10-27 English
Jon U. Garay Alonso blir ny Chief Financial Officer på Camurus
Board/Management Information
2021-10-13 Swedish
Camurus appoints Jon U. Garay Alonso as Chief Financial Officer
Board/Management Information
2021-10-13 English
Förändring av antalet aktier och röster i Camurus
Declaration of Voting Results & Voting Rights Announcements
2021-09-30 Swedish
Change in number of shares and votes in Camurus
Share Issue/Capital Change
2021-09-30 English
FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease
Regulatory Filings
2021-09-16 English
FDA beviljar särläkemedelsstatus i USA för CAM2029 för behandling av polycystisk leversjukdom
Regulatory Filings
2021-09-16 Swedish
Camurus’ Chief Financial Officer (CFO) will leave the company
Board/Management Information
2021-09-15 English
Camurus CFO kommer att sluta i bolaget
Board/Management Information
2021-09-15 Swedish
Change in number of shares and votes in Camurus
Declaration of Voting Results & Voting Rights Announcements
2021-08-31 English
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change
2021-08-31 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q2 2021
2021-07-16 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report H1 2021
2021-07-16 English
Change in number of shares and votes in Camurus
Declaration of Voting Results & Voting Rights Announcements
2021-06-30 English
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change
2021-06-30 Swedish
Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US
Regulatory Filings
2021-06-26 English
Camurus meddelar att FDA aviserat PDUFA-datum för Brixadi i USA
Regulatory Filings
2021-06-26 Swedish
Förändring av antalet aktier och röster i Camurus
Share Issue/Capital Change
2021-05-31 Swedish
Change in number of shares and votes in Camurus
Share Issue/Capital Change
2021-05-31 English
Resolutions at the annual general meeting 2021 in Camurus
AGM Information
2021-05-06 English
Beslut vid Camurus årsstämma 2021
AGM Information
2021-05-06 Swedish
Interim / Quarterly Report 2021
Interim / Quarterly Report Q1 2021
2021-05-06 Swedish
Earnings Release 2021
Earnings Release Q1 2021
2021-05-06 English
Annual Report 2020
Annual Report FY 2020
2021-04-14 Swedish
Annual Report 2020
Annual Report FY 2020
2021-04-14 English
Kallelse till årsstämma 2021 i Camurus AB (publ)
AGM Information
2021-03-30 Swedish
Notice of annual general meeting 2021 in Camurus AB (publ)
AGM Information
2021-03-30 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-03-08 English
Interim / Quarterly Report 2020
Interim / Quarterly Report Q4 2020
2021-02-11 Swedish
Audit Report / Information 2020
Audit Report / Information FY 2020
2021-02-11 English
Change in number of shares and votes in Camurus
Declaration of Voting Results & Voting Rights Announcements
2021-01-29 English
Förändring av antalet aktier och röster i Camurus
Declaration of Voting Results & Voting Rights Announcements
2021-01-29 Swedish